Characterizing the Pathophysiological Role of the Pallido-thalamocortical Motor Pathway in Parkinson's Disease.
NCT ID: NCT06692920
Last Updated: 2026-01-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
25 participants
INTERVENTIONAL
2024-12-01
2028-08-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Pathways Mediating Impaired Postural Control in Parkinson's Disease
NCT06464029
Deep Brain Stimulation in Patients With Parkinson's Disease
NCT00586079
Automated Parkinson's Disease (PD) Motor Symptom Assessment for Deep Brain Stimulation (DBS) Programming
NCT01429220
Invasive Approach to Model Human Cortex-Basal Ganglia Action-Regulating Networks
NCT03608228
Vestibular and Cortical Contributions to Transitions in Freezing of Gait in Parkinson's Disease
NCT06506058
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Intervention:
1. Stimulation through the DBS lead contact showing the most coherence with brain activity in the motor cortex
2. Stimulation through the DBS lead contact showing the least coherence with brain activity in the motor cortex
During the mapping session patients will either be asked to perform motor tasks such as finger-tapping, pronating/supinating the wrist, manipulating a joystick, or pointing to targets on a touch-sensitive, LCD positioned in front of them. Patients may also be asked to perform cognitive tasks such as maintaining items in working memory or deciding between potentially rewarding stimuli with either a joystick or a finger response pad.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Study group
Parkinson's patients with DBS surgery planned as part of routine clinical care
DBS stimulation
* Standard of care DBS surgery
* stimulation through the DBS lead during their DBS lead surgery, the study team will use 2 sets of stimulation settings on each participant:
1. Stimulation through the DBS contact whose electrical activity is the MOST similar to the area of the brain that controls movement
2. Stimulation through the DBS contact whose electrical activity is the LEAST similar to the area of the brain that controls movement
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
DBS stimulation
* Standard of care DBS surgery
* stimulation through the DBS lead during their DBS lead surgery, the study team will use 2 sets of stimulation settings on each participant:
1. Stimulation through the DBS contact whose electrical activity is the MOST similar to the area of the brain that controls movement
2. Stimulation through the DBS contact whose electrical activity is the LEAST similar to the area of the brain that controls movement
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* DBS surgery at UMN is planned as part of routine clinical care
* Aged 21-75
Exclusion Criteria
* History of dementia
* Patients with post-operative complications or adverse effects (e.g. ON stimulation dystonias) that affect patient safety or confound the experiment will be excluded from further study
* Pregnant women
* Known research radiation exposure within the last year that is determined to be unsafe when compounded with the expected radiation dose from intraoperative fluoroscopy
21 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Minnesota
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Joshua E Aman
Role: PRINCIPAL_INVESTIGATOR
University of Minnesota
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Minnesota
Minneapolis, Minnesota, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NEURO-2016-24971
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.